Literature DB >> 10602022

Co-ordination of the expression of the protein tyrosine kinase p56(lck) with the pre-T cell receptor during thymocyte development.

J Buckland1, D J Pennington, L Bruno, M J Owen.   

Abstract

The protein tyrosine kinase p56(lck) is essential for the regulation of early thymocyte development by transducing pre-T cell receptor (pre-TCR) mediated-signals. Here we have investigated the developmental timing of expression of p56(lck) in the thymus. We show that p56(lck) transcripts are detectable in each CD4(-)CD8(-) double-negative (DN) thymocyte subset defined by CD25 and CD44. The steady-state level of p56(lck) mRNA with these four DN subsets is similar, varying by less than 2-fold. However, p56(lck) protein levels are undetectable in DN subsets 1 and 2, but are at least 20-fold up-regulated between DN subsets 2 and 3. Analysis of independent transgenic mouse lines in which the proximal p56(lck) promoter was used to drive expression of a green fluorescent protein (GFP) reporter gene revealed a lack of correlation between GFP mRNA expression and transgene copy number and variable expression of GFP protein in different lines. Taken together these results show that the expression of the p56(lck) gene is developmentally regulated at the post-transcriptional level at the precise developmental stage at which its upstream receptor complex, the pre-TCR, is expressed. These results also have implications for the interpretation of the phenotype of transgenic mice which utilize the p56(lck) proximal promoter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10602022     DOI: 10.1002/1521-4141(200001)30:1<8::AID-IMMU8>3.0.CO;2-8

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

Review 1.  Progression of regulatory gene expression states in fetal and adult pro-T-cell development.

Authors:  Elizabeth-Sharon David-Fung; Mary A Yui; Marissa Morales; Hua Wang; Tom Taghon; Rochelle A Diamond; Ellen V Rothenberg
Journal:  Immunol Rev       Date:  2006-02       Impact factor: 12.988

2.  Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E.

Authors:  Andrew C Hsieh; Maria Costa; Ornella Zollo; Cole Davis; Morris E Feldman; Joseph R Testa; Oded Meyuhas; Kevan M Shokat; Davide Ruggero
Journal:  Cancer Cell       Date:  2010-03-16       Impact factor: 31.743

3.  A dominant interfering Bub1 mutant is insufficient to induce or alter thymic tumorigenesis in vivo, even in a sensitized genetic background.

Authors:  Dale O Cowley; Ginger W Muse; Terry Van Dyke
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

4.  Roles of the Src tyrosine kinases Lck and Fyn in regulating gammadeltaTCR signal strength.

Authors:  Renee M Laird; Sandra M Hayes
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

Review 5.  Thymus and aging: morphological, radiological, and functional overview.

Authors:  Rita Rezzani; Lorenzo Nardo; Gaia Favero; Michele Peroni; Luigi Fabrizio Rodella
Journal:  Age (Dordr)       Date:  2013-07-23

6.  Perturbed thymopoiesis in vitro in the absence of suppressor of cytokine signalling 1 and 3.

Authors:  Hayley A Croom; David J Izon; Mark M Chong; David J Curtis; Andrew W Roberts; Thomas W H Kay; Douglas J Hilton; Warren S Alexander; Robyn Starr
Journal:  Mol Immunol       Date:  2008-03-05       Impact factor: 4.407

7.  Activation of the Hedgehog signaling pathway in T-lineage cells inhibits TCR repertoire selection in the thymus and peripheral T-cell activation.

Authors:  Nicola J Rowbotham; Ariadne L Hager-Theodorides; Marek Cebecauer; Divya K Shah; Ekati Drakopoulou; Julian Dyson; Susan V Outram; Tessa Crompton
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

8.  Tissue-derived hedgehog proteins modulate Th differentiation and disease.

Authors:  Anna L Furmanski; Jose Ignacio Saldana; Masahiro Ono; Hemant Sahni; Nikolaos Paschalidis; Fulvio D'Acquisto; Tessa Crompton
Journal:  J Immunol       Date:  2013-02-13       Impact factor: 5.422

9.  A transgenic mouse model of human T cell leukemia virus type 1-associated diseases.

Authors:  Takeo Ohsugi
Journal:  Front Microbiol       Date:  2013-03-08       Impact factor: 5.640

10.  Activation kinetics and off-target effects of thymus-initiated cre transgenes.

Authors:  Jianjun Shi; Howard T Petrie
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.